Your Top 50 most-cited badge
A badge for your website, a sentence for your CV, and a permanent page where anyone can check the rank.
The article
Pembrolizumab in combination with nab-paclitaxel for the treatment of patients with early-stage triple-negative breast cancer – A single-arm phase II trial (NeoImmunoboost, AGO-B-041)
Peter Andreas Fasching, Alexander Hein, Hans‐Christian Kolberg, Lothar Häberle, Sabrina Uhrig, Matthias Rübner and 10 more
- Rank
- 41 of 474
- Percentile
- top 8.7%
- Where
- European Journal of Cancer, 2023
- Citations
- 39
From the 2023 list, OpenAlex counts as of 2026-10-29.
Prefer not to be listed? The same link lets you withhold your name on every list; the article stays, your name does not. Questions: team@avidnote.com.